A Phase I Study of TL32711 In Combination With Gemcitabine in Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 14 Jan 2014
At a glance
- Drugs Birinapant (Primary) ; Gemcitabine
- Indications Solid tumours
- Focus Adverse reactions
- 14 Jan 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 18 Apr 2012 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov.
- 17 Apr 2012 New trial record